Zhengye Biotechnology Holding reported total assets of $61.54M and total liabilities of $18.29M for the quarter ended Dec 2025. This balance sheet covers 5 quarters of results from Dec 2022 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2022 | Dec2023 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & EquivalentsCash & Equiv. | 1.37M | 3.78M | 2.59M | 6.37M | 7.10M |
| Short-term InvestmentsInvestments (Current) | 1.68M | 278.43 | 0.28M | 281.99 | |
| Cash & Current Investments | 1.37M | 5.46M | 2.59M | 6.31M | 7.10M |
| Receivables - NetNet Receivables | 12.89M | 10.64M | 7.41M | 5.15M | |
| Receivables - OtherOther Receivables | -562.42 | -0.10M | 0.10M | 0.10M | 0.10M |
| Receivables | 12.78M | 10.74M | 7.44M | 5.25M | |
| Raw Materials | 1.37M | 1.03M | 1.12M | ||
| Work In Process | 4.66M | 4.60M | 2.49M | ||
| Finished Goods | 2.06M | 2.47M | 1.91M | ||
| Inventory | 8.10M | 8.11M | 7.47M | 5.52M | |
| Prepaid Assets | 0.37M | 3.59M | 3.62M | ||
| Current Assets | 26.28M | 24.72M | 28.12M | 19.38M | |
| Non-Current Assets | |||||
| Buildings | 21.08M | 21.29M | 22.10M | ||
| Construction in Progress | 1.06M | 1.36M | 0.09M | ||
| Property, Plant & Equipment (Net)PP&E (Net) | 36.56M | 35.52M | 34.44M | 33.39M | |
| Long-Term Investments | 37.89M | 39.53M | 30.53M | ||
| Intangibles | 2.26M | 2.07M | 2.15M | 6.64M | |
| Goodwill & Intangibles | 2.26M | 2.07M | 2.12M | 6.64M | |
| Long-Term Deferred Tax | 1.65M | 1.53M | 2.28M | 0.01M | |
| Other Non-Current Assets | 0.90M | 2.60M | 2.37M | 0.99M | |
| Non-Current Assets | 43.14M | 43.95M | 42.32M | 42.16M | |
| Assets | 69.43M | 68.67M | 70.44M | 61.54M | |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payables | 6.34M | 5.98M | 5.97M | 6.21M | |
| Notes Payables | 10.36M | 11.29M | 9.18M | ||
| Dividends payables | 0.32M | 0.29M | 0.30M | 0.33M | |
| Payables | 6.66M | 16.63M | 17.40M | 15.71M | |
| Accumulated Expenses | 0.40M | 0.78M | 0.53M | 0.49M | |
| Other Accumulated Expenses | 4.35M | 0.02M | 4.56M | 4.60M | |
| Short term Debt | 11.09M | 1.00M | 0.03M | 0.10M | |
| Current Leases | 0.01M | ||||
| Current Taxes | 0.32M | 0.29M | 0.33M | ||
| Current Deferred Revenue | 0.54M | 0.49M | 0.70M | 0.67M | |
| Total Current Liabilities | 20.87M | 18.92M | 18.82M | 16.99M | |
| Non-Current Liabilities | |||||
| Non-Current Debt | 1.39M | 0.67M | 0.66M | 1.25M | |
| Preferred Stock Liabilities | 139.22 | 140.99 | |||
| Minority Interest | 9.23M | 9.55M | 9.24M | 8.02M | |
| Non-Current Deferred Tax LiabilityNon-Current Deferred Tax | 0.01M | ||||
| Operating Leases | 0.05M | ||||
| Other Non-Current Liabilities | 0.02M | ||||
| Total Non-Current Liabilities | 1.44M | 0.67M | 0.66M | 1.31M | |
| Total Liabilities | -50.18M | 22.31M | 19.59M | 19.48M | 18.29M |
| Shareholder's Equity | |||||
| Total Debt | 12.48M | 12.03M | 11.86M | 10.53M | |
| Common Equity | 50.18M | 47.12M | 49.08M | 50.97M | 43.24M |
| Liabilities and Shareholders Equity | 69.43M | 68.67M | 69.77M | 61.54M | |
| Retained Earnings | 5.33M | 6.70M | 3.70M | -3.05M |